SEC Form 4 · accession 0001179110-15-001574
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Hagen
Officer — SVP Pharmaceutical Dev & Mfg
Period of report
Jan 31, 2015
Accepted (ET)
Feb 3, 2015 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 31, 2015 | F | 529 | $0.00 | D | 30,404 | D | |
| Common Stock | Jan 31, 2015 | D | 1,250 | $0.00 | D | 29,154 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.
- F2Consists of shares forfeited due to performance conditions having not been met.